Related Experiment Video
Updated: Sep 27, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Cefuroxime resistance in non-beta-lactamase Haemophilus influenzae is linked to mutations in ftsI
K Straker1, M Wootton, A M Simm
1Bristol Centre of Antimicrobial Research and Evaluation (BCARE), Department of Pathology and Microbiology, University of Bristol, Bristol BS8 1TD, UK.
Abstract:
The penicillin binding protein (PBP) genes dacA, dacB and ftsI from 14 cefuroxime-resistant (CXM(R)) isolates and three clinical isolates with low CXM MIC for non-beta-lactamase-producing Haemophilus influenzae type b were molecularly characterized. One strain, 5788, was used to transform H. influenzae Rd to CXM(R) for direct comparison of the pbps in the same genetic background. No obvious mutations in the dacA and dacB gene products could be associated with CXM(R). One amino acid substitution in the ftsI gene product in particular, S357N, could give rise to CXM(R). Sequence analysis from the CXM(R) transformants also implicated FtsI; in this case, the substitutions were V511A and R517H. To verify S357N substitution, the protein sequence of H. influenzae FtsI was threaded through the S. pneumoniae PBP 2X structure giving an average root mean square deviation of the alpha-carbon chains of 0.5 A. The S357N substitution alters both the residue size and charge. One explanation for the contribution of S357N to CXM(R) is that the asparagine side-chain produces unfavourable steric hindrance with the side chain of Val-362 changing the torsion angles of the asparagine residue, which in turn may influence the position of the loop V362-P366 adjacent to the active site. Whilst other groups have examined the contribution of H. influenzae PBPs in ampicillin resistance, this is the first report analysing their role in CXM(R).
Insights
Cefuroxime resistance in Haemophilus influenzae type b is linked to specific mutations in the FtsI penicillin-binding protein (PBP) gene. This study identifies the S357N substitution as a key factor contributing to cefuroxime resistance.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Haemophilus influenzae type b is a significant pathogen.
- Antibiotic resistance, particularly to beta-lactams like cefuroxime, is a growing concern.
- Penicillin-binding proteins (PBPs) are crucial targets for beta-lactam antibiotics.
Purpose of the Study:
- To investigate the molecular basis of cefuroxime resistance (CXM(R)) in Haemophilus influenzae type b.
- To identify specific mutations in penicillin-binding protein (PBP) genes associated with CXM(R).
Main Methods:
- Molecular characterization of PBP genes (dacA, dacB, ftsI) from cefuroxime-resistant isolates.
- Genetic transformation experiments to confirm the role of identified mutations.
- Structural analysis of PBP FtsI to understand the impact of mutations.
Main Results:
- No significant mutations were found in dacA or dacB associated with CXM(R).
- A specific amino acid substitution, S357N, in the FtsI gene product was identified as a potential cause of CXM(R).
- Transformants also showed resistance linked to FtsI substitutions (V511A and R517H).
Conclusions:
- The FtsI gene is implicated in cefuroxime resistance in Haemophilus influenzae type b.
- The S357N substitution in FtsI is a key mutation conferring cefuroxime resistance.
- This study provides the first analysis of PBP roles in CXM(R) for H. influenzae.
More Related Videos
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial DNA Synthesis
Conjugation
Gene Regulation in Microbial Communities: Quorum Sensing

